Prestige BioPharma Statistics

Total Valuation

KRX:950210 has a market cap or net worth of KRW 108.65 billion. The enterprise value is 197.69 billion.

Market Cap	108.65B
Enterprise Value	197.69B

Important Dates

The next estimated earnings date is Friday, May 29, 2026.

Earnings Date	May 29, 2026
Ex-Dividend Date	n/a

Share Statistics

KRX:950210 has 12.02 million shares outstanding. The number of shares has increased by 0.25% in one year.

Current Share Class	n/a
Shares Outstanding	12.02M
Shares Change (YoY)	+0.25%
Shares Change (QoQ)	-0.69%
Owned by Insiders (%)	30.40%
Owned by Institutions (%)	0.11%
Float	3.59M

Valuation Ratios

The trailing PE ratio is 39.75.

PE Ratio	39.75
Forward PE	n/a
PS Ratio	5.71
PB Ratio	0.23
P/TBV Ratio	0.31
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	14.46
EV / Sales	10.39
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.96

Financial Position

The company has a current ratio of 1.03, with a Debt / Equity ratio of 0.18.

Current Ratio	1.03
Quick Ratio	0.74
Debt / Equity	0.18
Debt / EBITDA	n/a
Debt / FCF	-1.33
Interest Coverage	-9.58

Financial Efficiency

Return on equity (ROE) is -0.86% and return on invested capital (ROIC) is -14.94%.

Return on Equity (ROE)	-0.86%
Return on Assets (ROA)	-6.42%
Return on Invested Capital (ROIC)	-14.94%
Return on Capital Employed (ROCE)	-13.32%
Weighted Average Cost of Capital (WACC)	7.61%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.03
Inventory Turnover	0.98

Taxes

Income Tax	-318.57M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -40.93% in the last 52 weeks. The beta is 0.73, so KRX:950210's price volatility has been lower than the market average.

Beta (5Y)	0.73
52-Week Price Change	-40.93%
50-Day Moving Average	9,898.80
200-Day Moving Average	12,596.35
Relative Strength Index (RSI)	39.63
Average Volume (20 Days)	76,421

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:950210 had revenue of KRW 19.02 billion and earned 13.68 billion in profits. Earnings per share was 227.41.

Revenue	19.02B
Gross Profit	-4.89B
Operating Income	-73.03B
Pretax Income	-4.53B
Net Income	13.68B
EBITDA	-48.46B
EBIT	-73.03B
Earnings Per Share (EPS)	227.41

Full Income Statement

Balance Sheet

The company has 84.96 billion in cash and 88.62 billion in debt, giving a net cash position of -3.66 billion or -304.30 per share.

Cash & Cash Equivalents	84.96B
Total Debt	88.62B
Net Cash	-3.66B
Net Cash Per Share	-304.30
Equity (Book Value)	482.56B
Book Value Per Share	6,649.00
Working Capital	3.17B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -31.74 billion and capital expenditures -34.94 billion, giving a free cash flow of -66.68 billion.

Operating Cash Flow	-31.74B
Capital Expenditures	-34.94B
Depreciation & Amortization	24.57B
Net Borrowing	-67.07B
Free Cash Flow	-66.68B
FCF Per Share	-5,547.74

Full Cash Flow Statement

Margins

Gross margin is -25.70%, with operating and profit margins of -383.88% and 71.89%.

Gross Margin	-25.70%
Operating Margin	-383.88%
Pretax Margin	-23.81%
Profit Margin	71.89%
EBITDA Margin	-254.73%
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KRX:950210 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.25%
Shareholder Yield	-0.25%
Earnings Yield	12.59%
FCF Yield	-61.37%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KRX:950210 has an Altman Z-Score of -0.43 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.43
Piotroski F-Score	4